Skip to main content
Log in

Checkpoint inhibitors: costs of managing toxicities similar

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. cytotoxic T lymphocyte antigen 4

  2. 2015 US dollars

Reference

  • Mason NT, et al. Modeling the cost of immune checkpoint inhibitor-related toxicities. 52nd Annual Meeting of the American Society of Clinical Oncology : (plus poster) abstr. 6627, 3 Jun 2016. Available from: URL: http://meetinglibrary.asco.org/content/168780-176

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Checkpoint inhibitors: costs of managing toxicities similar. PharmacoEcon Outcomes News 758, 14 (2016). https://doi.org/10.1007/s40274-016-3243-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3243-6

Navigation